Recorded fact · drug.label_indication
drug.label_indication for acalabrutinib|chronic-lymphocytic-leukemia
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 0a13a96b resolves to.
The record
| Fact id | 0a13a96bd627723615475583 |
|---|---|
| Entity | drug: acalabrutinib|chronic-lymphocytic-leukemia |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260219 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
For the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 37de354509de432773bb8cfe5507323f0165a7aab23a95604ae1e47073a485f8.
The value
{
"ingredient": "ACALABRUTINIB",
"conditionId": "chronic-lymphocytic-leukemia",
"conditionName": "Chronic Lymphocytic Leukemia",
"matchedAlias": "chronic lymphocytic leukemia",
"context": "indication",
"brand": "CALQUENCE",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "dd4835ef-e1bc-4997-a399-1ffa2556fbfe",
"labelEffectiveTime": "20260219",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: a58ae105ad9528f325fdd7596500a6bc33d839942ed438df785fbf96e740f0f4.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.